Grid Exponential

SphereBio, established in 2023, specializes in developing biotechnology platforms that facilitate the delivery of molecules to cells, thereby training them to respond to specific health issues. The company leverages its platforms to provide pharmaceutical and veterinary businesses with innovative methods to enhance vaccines and therapeutics, tailored to combat diseases like cancer.

MicroIN is a biotechnology company that specializes in enhancing the stability and effectiveness of biological products, particularly in the agro-environmental sector. It achieves this by developing customized encapsulation protocols for microorganisms, improving their viability and optimizing bioinput formulations.

Polymera leverages the adaptive mechanisms of an extremophile antarctic bacterium to develop naturally biodegradable biopolymers.

MIGMA uses Artificial Intelligence to accelerate the discovery of new synergistic combinations of antioxidants.

BioBlends develops biopreservatives for the food industry to extend the shelf life of food products.

Apasomics is a biotechnology company specializing in bone-targeted drug delivery. It develops apasome-based nanocarriers to deliver bisphosphonates directly to bones, enhancing treatment efficacy for osteoporosis and other skeletal disorders while minimizing side effects. By combining nanotechnology and precision medicine, Apasomics aims to improve therapeutic outcomes and patient quality of life.

GlycoX is a biotechnology company specializing in innovative diabetes management solutions. It develops an oral solution aimed at controlling blood sugar levels, empowering diabetic patients and improving their quality of life. The company's approach combines natural elements with advanced technology, aiming to revolutionize diabetes treatment.

Nanoingreen is a green synthesis company focused on transforming plant-based products into functional foods through precision fermentation processes. The company develops specific formulations that enhance the nutritional profile and functionality of food products, enabling clients to create next-generation offerings with unique flavors and textures. By incorporating these formulations, Nanoingreen aims to address future health challenges and improve the overall quality of plant-based foods, positioning itself as a leader in the functional food market.

APEXzymes develops high-performance microbial technologies for the industrial production of biofertilizers and enzymes.

Dogma BioTech is a biotechnology firm that develops protein-based therapeutics.

AlgaLife is a biotechnology company that focuses on improving microalgae cultivation processes, enabling 95% cheaper production costs while maintaining high yields. The company's core product is a microalgae consortium designed to enhance aquaculture efficiency and sustainability. This consortium improves gut health and immunological activity in farmed aquatic animals, reducing mortality rates and enabling the aquaculture industry to meet sustainability challenges more effectively.

Ocular Bio Design is a tissue engineering company for the regeneration of visual function.

Smart delivery biocapsules that enhance crop production.

Aquit is a biotechnology company specializing in the development of preventive treatments for fish infections. Their innovative solutions aim to replace antibiotics, thereby enhancing fish immunity, improving survival rates, and promoting sustainable aquaculture practices.

Gisens Biotech is a biotechnology company specializing in bioelectronics and nanotechnology. The firm is recognized for its innovative approach to problem-solving and leverages advanced technology to meet its goals. A standout product is the Nano-Lab, a portable diagnostic device that measures and monitors various biomarkers from minimal samples of blood, urine, or saliva. This device is particularly adept at detecting renal biomarkers such as urea, creatinine, and potassium from a single drop of blood. By providing real-time tracking of these concentrations, the Nano-Lab enhances health monitoring capabilities, offering a high level of accuracy and convenience that has the potential to transform traditional biomarker measurement and interpretation methods.

Eywa is a biotechnology company specializing in the development of innovative production methods for psychedelic medicines. It focuses on designing efficient processes and products to enhance the adoption of these treatments, leveraging biosynthesis to create patient-centered therapies aimed at improving mental health outcomes.

Fungi Life is a biotech company specializing in the innovative production of biosurfactants derived from fungal biotechnology. By utilizing fungi, the firm develops sustainable alternatives to synthetic surfactants and enzymes, aiming to replace harmful petroleum-based ingredients across various industries, including oil and gas, cleaning, cosmetics, agriculture, and personal care. Fungi Life's approach focuses on enhancing product biodegradability and reducing environmental impact, positioning the company as a leader in promoting eco-friendly solutions within the biotechnology sector.

Updairy is a company that produces food ingredients, specifically animal-free dairy proteins. It uses microorganisms to create these proteins, replicating the taste and nutritional value of traditional dairy products while significantly reducing greenhouse gas emissions. This allows customers to develop new dairy products with a lower environmental impact than traditional dairy farming.

Kresko RNAtech is a biotechnology company focused on the development and production of nutraceuticals. It specializes in identifying bioactive ribonucleic acids (RNAs) from natural sources, utilizing advanced techniques such as machine learning and bioinformatics. By discovering RNAs that may offer health benefits, Kresko RNAtech aims to assist researchers in enhancing human well-being and addressing the challenges posed by stressful and changing environments through innovative RNA technologies.

Nanotransfer specializes in the development of advanced delivery systems utilizing inorganic nanoparticles for gene therapy applications. These systems offer several advantages, including readiness for immediate use by clients, versatility in transporting various types of nucleic acids, and biosafety characteristics, such as non-immunogenicity, allowing for broad patient eligibility and potential re-administration. The delivery systems are designed for high levels of cellular internalization and can be tailored for specificity towards particular cell types, facilitating customized therapies. Furthermore, they possess chemical affinities for the phosphate backbone of nucleic acids, which enhances their ability to integrate genes irrespective of sequence. This approach enables the decoupling of synthesis for the delivery system and the gene of interest, promoting the development of a wider range of therapies aimed at improving health outcomes. Notably, Nanotransfer's non-viral delivery systems can evade endosomal entrapment and resist enzymatic degradation due to their unique composition and surface properties.

Cryosmetics is a company dedicated to advancing the future of cosmetics through the development of innovative skincare products. The firm focuses on skincare technology that emphasizes the importance of the skin microbiome, leveraging a blend of technology, science, and biology. Cryosmetics creates products using natural raw materials, ensuring that they are free from preservatives and synthetic chemicals. This commitment enables customers to enhance their well-being while promoting diversity in the skin microbiome.

Fecundis is a company based in Rosario, Argentina, specializing in reproductive biology. It develops innovative solutions aimed at improving sperm competence and enhancing the success rates of assisted reproductive technologies. By utilizing advanced technology grounded in scientific research, Fecundis focuses on increasing sperm functionality and generating higher quality embryos, ultimately enabling patients to achieve successful pregnancies through fertility treatments.

CASPR Biotech is a San Francisco-based company established in 2018 that specializes in the development of a CRISPR-based platform for diagnosing antimicrobial resistances (AMR) and infectious diseases. The company focuses on creating portable diagnostic kits that utilize proprietary CRISPR Cas enzymes to detect specific DNA and RNA sequences, as well as signature amino acid sequences associated with infectious diseases and genetic mutations. These kits are designed to provide clinicians with a simple, fast, and affordable solution for molecular detection, enhancing the efficiency of disease identification in clinical and hospital settings.

Feedvax is an innovative company based in Argentina, established in 2018, focused on developing a platform for oral vaccines aimed at improving animal health in aquaculture. Its primary product is an oral vaccine designed to protect farmed tilapia from streptococcosis, a common disease affecting this widely farmed species. Feedvax's platform not only delivers vaccines but also provides a smart feeder that ensures nutritional and health treatments are administered automatically and individually to each animal. The company's solution is environmentally safe, cost-effective, and easy for farmers to use, promoting greater efficiency in animal production while helping to eliminate the need for antibiotics and reducing stress on the fish. By transforming traditional aquaculture practices, Feedvax aims to make a sustainable impact on the industry.

Algaebio+ is a company based in Argentina that specializes in the production of natural astaxanthin, a powerful antioxidant derived from the microalga Haematococcus pluvialis. This product is designed to offer a range of health benefits, including immunoregulatory, anti-inflammatory, and photo-protective properties, as well as potential applications in anti-aging and cancer prevention. Algaebio+ cultivates astaxanthin under controlled laboratory conditions before transitioning the production to photobioreactors. The company's offerings target various industries, including pharmaceuticals, nutraceuticals, functional foods, and cosmetics, where they aim to replace artificial pigments with their natural product. Additionally, astaxanthin is known to support joint, muscle, vision, and heart health, contributing to more effective treatments for chronic diseases.

Aplife Biotech is an Argentine biotechnology startup founded in 2018, based in Buenos Aires. The company focuses on developing innovative technologies for the high-throughput discovery of novel aptamers, which are synthetic DNA-derived molecules used in biosensors. Aplife Biotech's platform enables the manufacture of large combinatorial libraries of these aptamers in predefined locations, facilitating the mass screening of important biological molecules. This technology addresses global challenges in medical diagnostics by supporting the creation of novel biosensors and diagnostic assays, as well as therapeutic applications.